Tula
Payments companies reported to CMS as associated with Tula. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tula, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tula
These are the largest totals companies reported as associated with Tula. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jordan Schramm | Provo, UT | Pediatric Otolaryngology | $130,165.35 |
| Joshua Greene | Anderson, IN | Otolaryngology | $48,229.12 |
| Zorik Spektor | Boynton Beach, FL | Pediatric Otolaryngology | $37,797.64 |
| Kelvin Kwong | New Brunswick, NJ | Pediatric Otolaryngology | $34,088.79 |
| Jonathan Walsh | Baltimore, MD | Pediatric Otolaryngology | $17,896.27 |
| Ryan Walker | Cherry Hill, NJ | Pediatric Otolaryngology | $9,737.38 |
| Aaron Fritts | Dallas, TX | Vascular & Interventional Radiology | $6,300.00 |
| Don Respler | Orlando, FL | Otolaryngology | $4,313.57 |
| John Cho | Honolulu, HI | Otolaryngology | $3,242.59 |
| Flavio Oliveira | Mountain View, CA | Otolaryngology | $3,140.47 |
Prescribed Tula?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.